Effects of Standing at Different Angles on Transpulmonary Pressure
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Effects of standing at different angles on transpulmonary pressure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2020
CompletedFirst Posted
Study publicly available on registry
June 30, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedJuly 7, 2020
June 1, 2020
1 year
June 26, 2020
July 1, 2020
Conditions
Outcome Measures
Primary Outcomes (5)
transpulmonary pressure
End-expiratory pressure across the lungs is recommended at 0-5cmH2O.
5 minutes
Esophageal pressure
The change in esophageal pressure represents the degree of inspiratory effort.The greater the variation, the harder the inhale.
5 minutes
Dead space rate
the smaller,the better
5 minutes
tidal volume
Standard tidal volume: standard weight based on height, 6 to 8ml per kg body weight
5 minutes
partial pressure of carbon dioxide in endexpiratory gas
The smaller the difference between pCO2 and arterial blood gas, the better
5 minutes
Secondary Outcomes (1)
adverse reaction
an hour
Study Arms (1)
Standing Angle
EXPERIMENTALAssist the electric hospital bed to conduct different Angle standing training, starting from 20 degrees, every five minutes to rise 5 degrees, the maximum rise to 80 degrees
Interventions
Change the patient's standing Angle by using an electric bed
Eligibility Criteria
You may qualify if:
- The age is ≥ 18 years old;
- the hemodynamics is stable;
- \< heart rate \< 120 beats / min ;
- \< systolic blood pressure \< 200mmHg ;
- \< mean arterial pressure \< 120mmHg;
- do not increase the dose of pressor drugs for at least 2 hours;
- intracranial pressure is stable and there are no seizures within 24 hours;
- the respiratory state is stable;
- the patient's finger pulse oxygen saturation ≥ 88%;
- \< respiratory frequency \< 35 beats / min.
You may not qualify if:
- Pregnancy;
- acute cardio-cerebrovascular events;
- spinal or limb fractures;
- active bleeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
xin li xie, Ph.D.
The First Medical Center of PLA General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
June 26, 2020
First Posted
June 30, 2020
Study Start
October 1, 2020
Primary Completion
October 1, 2021
Study Completion
October 1, 2021
Last Updated
July 7, 2020
Record last verified: 2020-06